Huons receives A grade in ESG evaluation

South Korea’s Huons Co. said on Tuesday that it received an A (excellent) grade in the 2024 ESG evaluation recently released by the Korea Inst...
South Korea’s Huons Co. said on Tuesday that it received an A (excellent) grade in the 2024 ESG evaluation recently released by the Korea Inst...
South Korea's Icure Pharmaceutical Incorporation announced on Tuesday that it signed a supply contract for the specialized local anesthetic lidoca...
South Korea's Huons Group is continuing its record-breaking performance while expanding its influence in the global market.According to Huons Group ...
South Korean pharmaceutical firm, Huons Co., announced on Monday that it has secured another significant regulatory milestone in the US with the Foo...
South Korea’s Huons Co., an anesthetics vial producer, aims to triple its lidocaine output from 2026, targeting the US market, where it fills ...
Huons Co., a South Korean pharmaceutical company, has announced plans to expand its presence in the North American market by offering two anesthetic...